This study investigated whether external skin stimulation (exteroception) can regulate visceral neuroimmune responses, specifically examining a skin-lung reflex in which auricular TRPV1+ sensory neurons suppress *Alternaria alternata*-induced allergic airway inflammation in animal models.
Pharmacologic, chemogenetic, and optogenetic activation of auricular TRPV1+ afferents reduced type 2 allergic airway inflammation — including ILC2, eosinophil, and type 2 cytokine responses — while silencing these neurons worsened lung inflammation; the suppressive effect depended on the neuropeptide CGRPβ.
Findings are based on animal/preclinical models; translation to human allergic airway disease is not yet established. The precise circuit architecture between auricular ganglia and lung immune effectors warrants further mapping. Therapeutic parameters for transcutaneous neuromodulation in humans remain undefined.
This is early preclinical work, but it raises the possibility that transcutaneous auricular neuromodulation (e.g., vagus nerve stimulation via the ear) could one day be used to dampen airway inflammation in allergic diseases like asthma. Clinicians should watch for translational trials building on this mechanistic foundation.
